• All News
• 2021
• 2020
• 2019
• 2017
• 2016
• 2015
• 2014

Xenetic Biosciences Reports 2016 Year End Financial Results and Provides Business Update

Apr 3, 2017

Xenetic Biosciences to Ring Nasdaq Stock Market Opening Bell on March 30, 2017

Mar 29, 2017

Xenetic Biosciences Provides Update on Patent Portfolio Development

Mar 27, 2017

Xenetic Biosciences to Present at the 29th Annual ROTH Conference

Mar 9, 2017

Xenetic Biosciences Receives $3 Million Milestone Payment from Shire plc for PSA-Recombinant SHP656 in Development for Long-Acting Treatment for Hemophilia

Jan 6, 2017

Xenetic Biosciences Appoints Curtis A. Lockshin, Ph.D. as Chief Scientific Officer

Jan 4, 2017

Xenetic Biosciences to Present at Biotech Showcase 2017

Jan 3, 2017

Xenetic Biosciences Expands Management Team with Key Appointment of Jeffrey F. Eisenberg as Chief Operating Officer

Dec 5, 2016

Xenetic Biosciences to Present at the LD Micro 2016 Annual Conference

Dec 1, 2016

Xenetic Biosciences to Host Quarterly Update Conference Call and Webcast

Nov 23, 2016

• « Previous
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• ...11
• Next »